Literature DB >> 28079621

Effects of Education and Information on Vaccination Behavior in Patients with Inflammatory Bowel Disease.

Sofie Coenen1, Ellen Weyts, Cedric Jorissen, Paul De Munter, Maja Noman, Vera Ballet, Séverine Vermeire, Gert Van Assche, Marc Ferrante.   

Abstract

BACKGROUND: Despite the existence of international guidelines, vaccination in patients with inflammatory bowel disease (IBD) has not been integrated optimally. We developed a thorough education program, and compared its influence on vaccination rates with routine clinical practice in a tertiary IBD center.
METHODS: Between December 2014 and March 2015, we included 505 consecutive patients with IBD visiting our outpatient clinic (53% men, 72% Crohn's disease, median age 44 years). Vaccination data, including hepatitis B, influenza, pneumococcus, tetanus, and varicella zoster virus, as well as demographic data, were collected by a fellow in training or a certified gastroenterologist. Thereafter, patients were randomly assigned to group A receiving routine clinical practice or intervention group B receiving additional education by the IBD nurse with help of an information brochure and vaccination card. Vaccination status was reassessed 8 months later.
RESULTS: At baseline, 32% of patients were vaccinated according to the guidelines. The remaining 346 patients were randomized to group A (n = 206) or intervention group B (n = 140). Eight months after randomization, 33% of intervention group B versus 6% of group A followed vaccination recommendations and differences were significant for each vaccine (all P < 0.001). A higher educational level was independently associated with better compliance to pneumococcal vaccination (P = 0.008) and to the guidelines overall (P < 0.001). However, the educational intervention was the only consistent factor independently associated with improved compliance to each individual vaccination recommendation (all P ≤ 0.023).
CONCLUSIONS: Introduction of thorough vaccination education significantly increased compliance to vaccination guidelines. However, further education of patients and health care providers remains necessary.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28079621     DOI: 10.1097/MIB.0000000000001013

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  9 in total

Review 1.  British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults.

Authors:  Christopher Andrew Lamb; Nicholas A Kennedy; Tim Raine; Philip Anthony Hendy; Philip J Smith; Jimmy K Limdi; Bu'Hussain Hayee; Miranda C E Lomer; Gareth C Parkes; Christian Selinger; Kevin J Barrett; R Justin Davies; Cathy Bennett; Stuart Gittens; Malcolm G Dunlop; Omar Faiz; Aileen Fraser; Vikki Garrick; Paul D Johnston; Miles Parkes; Jeremy Sanderson; Helen Terry; Daniel R Gaya; Tariq H Iqbal; Stuart A Taylor; Melissa Smith; Matthew Brookes; Richard Hansen; A Barney Hawthorne
Journal:  Gut       Date:  2019-09-27       Impact factor: 23.059

2.  Inflammatory Bowel Disease and COVID-19 Vaccination: A Patients' Survey.

Authors:  Bénédicte Caron; Elise Neuville; Laurent Peyrin-Biroulet
Journal:  Dig Dis Sci       Date:  2021-05-12       Impact factor: 3.487

Review 3.  Shared Decision Making Enhances Pneumococcal Vaccination Rates in Adult Patients in Outpatient Care.

Authors:  Flora Kuehne; Linda Sanftenberg; Tobias Dreischulte; Jochen Gensichen
Journal:  Int J Environ Res Public Health       Date:  2020-12-07       Impact factor: 3.390

4.  Assessment of patients' understanding of inflammatory bowel diseases: Development and validation of a questionnaire.

Authors:  Gaiana Ostromohov; Morin Fibelman; Ayal Hirsch; Yulia Ron; Nathaniel Aviv Cohen; Revital Kariv; Liat Deutsch; Jasmine Kornblum; Ronit Anbar; Nitsan Maharshak; Naomi Fliss-Isakov
Journal:  United European Gastroenterol J       Date:  2021-12-23       Impact factor: 4.623

5.  A single dedicated vaccination visit improves vaccination coverage of patients with inflammatory bowel disease.

Authors:  Guillaume Le Cosquer; Lionel Grangeon; Pauline Rivière; Arthur Berger; Frank Zerbib; David Laharie; Florian Poullenot
Journal:  Therap Adv Gastroenterol       Date:  2022-04-20       Impact factor: 4.802

Review 6.  Trends in guideline implementation: an updated scoping review.

Authors:  Sanne Peters; Krithika Sukumar; Sophie Blanchard; Akilesh Ramasamy; Jennifer Malinowski; Pamela Ginex; Emily Senerth; Marleen Corremans; Zachary Munn; Tamara Kredo; Lucia Prieto Remon; Etienne Ngeh; Lisa Kalman; Samia Alhabib; Yasser Sami Amer; Anna Gagliardi
Journal:  Implement Sci       Date:  2022-07-23       Impact factor: 7.960

Review 7.  Management of hepatitis B virus infection in patients with inflammatory bowel disease under immunosuppressive treatment.

Authors:  Georgios Axiaris; Evanthia Zampeli; Spyridon Michopoulos; Giorgos Bamias
Journal:  World J Gastroenterol       Date:  2021-07-07       Impact factor: 5.742

8.  How to Face the Advent of SARS-CoV-2 Vaccination in IBD Patients: Another Task for Gastroenterologists.

Authors:  Alfredo Papa; Franco Scaldaferri; Lorenzo Maria Vetrone; Matteo Neri; Antonio Gasbarrini; Loris Riccardo Lopetuso
Journal:  Vaccines (Basel)       Date:  2021-03-12

Review 9.  Update on Vaccinating the Patient With Inflammatory Bowel Disease.

Authors:  Jennifer Coukos; Francis A Farraye
Journal:  Curr Treat Options Gastroenterol       Date:  2018-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.